[HTML][HTML] Recent update on the anti-inflammatory activities of propolis

F Zulhendri, R Lesmana, S Tandean, A Christoper… - Molecules, 2022 - mdpi.com
In recent years, research has demonstrated the efficacy propolis as a potential raw material
for pharmaceuticals and nutraceuticals. There is limited report detailing the mechanisms of …

Pathogenesis‐directed therapy of 2019 novel coronavirus disease

CW Stratton, YW Tang, H Lu - Journal of medical virology, 2021 - Wiley Online Library
The 2019 novel coronavirus disease (COVID‐19) now is considered a global public health
emergency. One of the unprecedented challenges is defining the optimal therapy for those …

Hyper‐inflammation and complement in COVID‐19

BG Pires, RT Calado - American Journal of Hematology, 2023 - Wiley Online Library
COVID‐19 is a complex disease manifesting in a broad severity spectrum and involving
distinct organs and systems. Hyperinflammation, including complement over‐activation, has …

[HTML][HTML] Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review

A Kröker, M Tirzīte - Respiratory Research, 2021 - Springer
Background The COVID-19 pandemic has affected the world extraordinarily. This disease
has a potential to cause a significantly severe course of disease leading to respiratory …

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18: 0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

L Reverté, E Yeregui, M Olona… - Clinical and …, 2022 - Wiley Online Library
Dear Editor, The mechanistic pathways leading to immune dysregulation and complications
driven by uncontrolled severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …

Rational Use of Methylene Blue in COVID-19 Treatment

BV Saikrupa, M Muthukumar, S Kavya… - Journal of Drug Delivery …, 2022 - jddtonline.info
Methylene blue entered the medical field when Robert Koch and Paul Ehrlich introduced the
staining of tuberculosis microorganisms using methylene blue. It is used as an anesthetic …

[HTML][HTML] Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase

J Peraire, G García-Pardo, S Chafino… - European Journal of …, 2024 - Springer
Background COVID-19 pneumonia causes hyperinflammatory response that culminates in
acute respiratory syndrome (ARDS) related to increased multiorgan dysfunction and …

The immune response to SARS-CoV-2: mechanisms, aging, sequelae, and vaccines

C Espinoza, M Alarcón - Mini Reviews in Medicinal Chemistry, 2022 - ingentaconnect.com
This review seeks to clarify the factors involved in the various immune responses to
SARSCoV-2 infection and the mechanisms that influence the development of COVID-19 with …

[HTML][HTML] An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of …

EY Merigeon, D Yang, EA Ihms, LC Bassit… - Pathogens and …, 2022 - ncbi.nlm.nih.gov
Background: The continued emergence of SARS-CoV-2 variants has caused concern that a
constantly evolving virus will escape vaccines and antibody therapies. New approaches are …

[HTML][HTML] Predicting severe or critical symptoms in hospitalized patients with COVID-19 from Yichang, China

X Chen, F Peng, X Zhou, J Zhu, Y Gong… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
Objectives: We aimed to identify potential risk factors for severe or critical coronavirus
disease 2019 (COVID-19) and establish a prediction model based on significant factors …